Table 1 The clinical information for TCGA UCEC dataset.

From: Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma

Characteristics

Alive(N = 449)

Dead(N = 87)

Total(N = 536)

pvalue

FDR

Age

     

Mean ± SD

63.36 ± 11.02

66.69 ± 10.85

63.90 ± 11.05

  

Median[min-max]

63.00[31.00,90.00]

67.00[35.00,88.00]

64.00[31.00,90.00]

  

BMI

     

Mean ± SD

33.59 ± 9.15

32.74 ± 8.81

33.45 ± 9.09

  

Median[min-max]

32.42[17.36,81.64]

31.62[18.07,61.03]

32.21[17.36,81.64]

  

Histological type

   

2.10E-06

4.30E-06

Endometrioid

354(66.04%)

46(8.58%)

400(74.63%)

  

Mixed

16(2.99%)

6(1.12%)

22(4.10%)

  

Serous

79(14.74%)

35(6.53%)

114(21.27%)

  

Stage

   

3.40E-12

1.00E-11

Stage I

304(56.72%)

29(5.41%)

333(62.13%)

  

Stage II

42(7.84%)

9(1.68%)

51(9.51%)

  

Stage III

90(16.79%)

33(6.16%)

123(22.95%)

  

Stage IV

13(2.43%)

16(2.99%)

29(5.41%)

  

Grade

   

5.00E-06

5.00E-06

G1

95(17.72%)

2(0.37%)

97(18.10%)

  

G2

105(19.59%)

14(2.61%)

119(22.20%)

  

G3

249(46.46%)

71(13.25%)

320(59.70%)